This year's Nobel prize in chemistry was awarded to University of Washington professor David Baker and two scientists from ...

Pfizer, this name was all around the globe when the COVID-19 pandemic, as the American pharma giant was one of the first ...

Al-Madina Pharmaceuticals, a publicly listed firm on the SME platform, has proposed a 12% cash dividend exclusively for its general shareholders, excluding sponsor-directors, despite a 44% decline in ...

With that in mind, let's examine two pharma stocks that are incredibly cheap and which are worth buying right now, assuming ...

Four IPOs each raised at least $75 million this week as the Fall IPO market continued to hum along, while one company ...

Check local perspective on a topic that doesn't have so much to do with medical need but the cost of doing biz in the urban ...

According to Insider Monkey’s data, 21 hedge funds held stakes in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) as of Q2, with a ...

But, for the first time, injecting epinephrine isn’t the only option. A San Diego-based company, ARS Pharmaceuticals, has ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Generic drug giant Teva Pharmaceuticals has agreed to pay $450 million to settle two cases brought by the Department of ...

Michigan's Supreme Court reexamines rulings that may affect how the state's consumer protection laws apply to insulin pricing ...